Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin
https://pubmed.ncbi.nlm.nih.gov/36991096/
京都大学 島津 裕 Sci Rep.2023 Mar 29;13(1):5159.
![](https://myeloma.jp/wp-content/themes/cocoon-master/screenshot.jpg)
Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin
https://pubmed.ncbi.nlm.nih.gov/36991096/